Application of ACOSOG Z1071: Effect of Results on Patient Care and Surgical Decision-Making

Clinical Breast Cancer - Tập 18 - Trang 270-275 - 2018
Jacquelyn A.V. Palmer1, Teresa Flippo-Morton2, Kendall K. Walsh2, Lejla Hadzikadic Gusic2, Terry Sarantou2, Myra M. Robinson3, Richard L. White2
1Surgical Breast Oncology, Mercy Health, Fairfield Hospital, Fairfield, OH
2Division of Surgical Oncology, Levine Cancer Institute, Charlotte, NC
3Department of Biostatistics, Levine Cancer Institute, Charlotte, NC

Tài liệu tham khảo

Krag, 2007, Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial, Lancet Oncol, 8, 881, 10.1016/S1470-2045(07)70278-4

Giuliano, 2011, Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial, JAMA, 305, 569, 10.1001/jama.2011.90

Giuliano, 2010, Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial, Ann Surg, 252, 426, 10.1097/SLA.0b013e3181f08f32

Boughey, 2013, Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial, JAMA, 310, 1455, 10.1001/jama.2013.278932

Balas, 2000, Managing clinical knowledge for health care improvement, Yearb Med Inform, 65

Lenfant, 2003, Shattuck lecture–clinical research to clinical practice–lost in translation?, N Engl J Med, 349, 868, 10.1056/NEJMsa035507

Nieva, 2005, From science to service: a framework for the transfer of patient safety research into practice

Eastern Association for the Surgery of Trauma (EAST) Ad Hoc Committee on Practice Management Guideline Development. Utilizing Evidence Based Outcome Measures to Develop Practice Management Guidelines 2000 EAST; 2000, Available at: www.east.org/content/documents/east_pmg_primer.pdf.

Morris, 2011, The answer is 17 years, what is the question: understanding time lags in translational research, J R Soc Med, 104, 510, 10.1258/jrsm.2011.110180

Caudle, 2012, American College of Surgeons Oncology Group (ACOSOG) Z0011: impact on surgeon practice patterns, Ann Surg Oncol, 19, 3144, 10.1245/s10434-012-2531-z

Wright, 2015, Measuring the impact of the American College of Surgeons Oncology Group Z0011 trial on breast cancer surgery in a community health system, Am J Surg, 209, 240, 10.1016/j.amjsurg.2014.07.001

Stell, 2011, Sentinel lymph node biopsy after neo-adjuvant chemotherapy in breast cancer, Breast J, 17, 71, 10.1111/j.1524-4741.2010.01038.x

2009, 419

Alvarado, 2012, The role for sentinel lymph node dissection after neoadjuvant chemotherapy in patients who present with node-positive breast cancer, Ann Surg Oncol, 19, 3177, 10.1245/s10434-012-2484-2

Cortazar, 2014, Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis, Lancet, 384, 164, 10.1016/S0140-6736(13)62422-8

Park, 2013, Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with cytologically proven node-positive breast cancer at diagnosis, Ann Surg Oncol, 20, 2858, 10.1245/s10434-013-2992-8

Schneeweiss, 2013, Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA), Ann Oncol, 24, 2278, 10.1093/annonc/mdt182

Kuehn, 2013, Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study, Lancet Oncol, 14, 609, 10.1016/S1470-2045(13)70166-9

Mittendorf, 2014, Implementation of the American College of Surgeons Oncology Group z1071 trial data in clinical practice: is there a way forward for sentinel lymph node dissection in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy?, Ann Surg Oncol, 21, 2468, 10.1245/s10434-014-3775-6

Boileau, 2015, Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study, J Clin Oncol, 33, 258, 10.1200/JCO.2014.55.7827

Takei, 2013, Sentinel lymph node biopsy after neoadjuvant chemotherapy predicts pathological axillary lymph node status in breast cancer patients with clinically positive axillary lymph nodes at presentation, Int J Clin Oncol, 18, 547, 10.1007/s10147-012-0418-4

Caudle, 2016, Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection, J Clin Oncol, 34, 1072, 10.1200/JCO.2015.64.0094

Yao, 2015, Impact of the American College of Surgeons Oncology Group Z0011 randomized trial on the number of axillary nodes removed for patients with early-stage breast cancer, J Am Coll Surg, 221, 71, 10.1016/j.jamcollsurg.2015.02.035

Thông tin
Thông tin xuất bản

Clinical Breast Cancer

Tập 18

270-275

Thông tin tác giả